Works matching IS 07703198 AND DT 2019 AND VI 38 AND IP 2

Results: 46
    1
    2
    3

    Correction to: the efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.

    Published in:
    Clinical Rheumatology, 2019, v. 38, n. 2, p. 617, doi. 10.1007/s10067-018-4378-6
    By:
    • Liu, Xia;
    • Li, Xiaomei;
    • Li, Xiangpei;
    • Li, Zhijun;
    • Zhao, Dongbao;
    • Liu, Shengyun;
    • Zhang, Miaojia;
    • Zhang, Fengxiao;
    • Zhu, Ping;
    • Chen, Jinwei;
    • Wei, Wei;
    • Lin, Bing;
    • Zhou, Yingbo;
    • Chen, Jing;
    • Pang, Yafei;
    • Zhang, Lei;
    • Sun, Xiaoxuan;
    • Yu, Zhibo;
    • Jia, Yun;
    • Wang, Jia
    Publication type:
    Article
    4
    5
    6

    Rheumatology in and from Slovenia.

    Published in:
    Clinical Rheumatology, 2019, v. 38, n. 2, p. 271, doi. 10.1007/s10067-018-4307-8
    By:
    • Adebajo, Ade;
    • Espinoza, Luis R.
    Publication type:
    Article
    7

    Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind.

    Published in:
    Clinical Rheumatology, 2019, v. 38, n. 2, p. 563, doi. 10.1007/s10067-018-4304-y
    By:
    • Scott, Christiaan;
    • Chan, Mercedes;
    • Slamang, Waheba;
    • Okong'o, Lawrence;
    • Petty, Ross;
    • Laxer, Ronald M.;
    • Katsicas, María-Martha;
    • Fredrick, Francis;
    • Chipeta, James;
    • Faller, Gail;
    • Pileggi, Gecilmara;
    • Saad-Magalhaes, Claudia;
    • Wouters, Carine;
    • Foster, Helen E.;
    • Kubchandani, Raju;
    • Ruperto, Nicolino;
    • Russo, Ricardo
    Publication type:
    Article
    8
    9

    The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs—BioRx.si

    Published in:
    Clinical Rheumatology, 2019, v. 38, n. 2, p. 297, doi. 10.1007/s10067-018-4324-7
    By:
    • Rotar, Žiga;
    • Tomšič, Matija;
    • Praprotnik, Sonja;
    • on behalf of the Slovenian Rheumatologists
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    The incidence of giant cell arteritis in Slovenia.

    Published in:
    Clinical Rheumatology, 2019, v. 38, n. 2, p. 285, doi. 10.1007/s10067-018-4236-6
    By:
    • Pucelj, Nataša Potočnik;
    • Hočevar, Alojzija;
    • Ješe, Rok;
    • Rotar, Žiga;
    • Hawlina, Marko;
    • Fakin, Ana;
    • Pižem, Jože;
    • Tomšič, Matija
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.

    Published in:
    Clinical Rheumatology, 2019, v. 38, n. 2, p. 407, doi. 10.1007/s10067-018-4228-6
    By:
    • Fabiani, Claudia;
    • Vitale, Antonio;
    • Rigante, Donato;
    • Emmi, Giacomo;
    • Bitossi, Alice;
    • Lopalco, Giuseppe;
    • Sota, Jurgen;
    • Guerriero, Silvana;
    • Orlando, Ida;
    • Gentileschi, Stefano;
    • Iannone, Florenzo;
    • Frediani, Bruno;
    • Galeazzi, Mauro;
    • Vannozzi, Lorenzo;
    • Tosi, Gian Marco;
    • Cantarini, Luca
    Publication type:
    Article